Caeli Vascular is Therapeutic Devices in United States that focus on thrombus microemboli business. Founded in 2019. They cover business area such as developer, venous thrombectomy device, minimal invasive treatment, blood clot, large vein, mechanical, chemical and suction thrombectomy feature, efficient fragmentation, evacuation, thrombus microemboli, doctor, clinician, clinical thrombectomy outcome, vein wall trauma, distal microembolization, peri-procedural blood loss.
2019
( 5 years old in 2024 )
Thrombus Microemboli
-
P.O. Box 168
Chesterfield, MO 63005
United States
Private
developervenous thrombectomy deviceminimal invasive treatmentblood clotlarge veinmechanical, chemical and suction thrombectomy featureefficient fragmentationevacuationthrombus microembolidoctorclinicianclinical thrombectomy outcomevein wall traumadistal microembolizationperi-procedural blood loss
* We use standard office opening hours in near Caeli Vascular's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Caeli Vascular is Therapeutic Devices business from United States that founded in 2019 (5 years old in 2024), Caeli Vascular business is focusing on Thrombus Microemboli.
Caeli Vascular headquarter office and corporate office address is located in P.O. Box 168 Chesterfield, MO 63005 United States.
Caeli Vascular was founded in United States.
In 2024, Caeli Vascular is currently focus on thrombus microemboli sector.
Above is snippet of Google Trends for "thrombus microemboli" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Caeli Vascular, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
